The Pros and Cons of Using AI in Developing Scientific Communications

AI is rapidly reshaping scientific communications — but speed and scale don’t replace judgment. In a July 7, 2025 MedAdNews article, AbelsonTaylor Group’s Colleen Loughney explores where AI meaningfully improves efficiency in medical writing and where human expertise remains non-negotiable. Drawing on two decades of experience at the intersection of clinical science, strategy, and regulation, she outlines the real opportunities, real risks, and the responsibility agencies have when patient safety and trust are on the line.

Read more: The Pros and Cons of Using AI in Developing Scientific Communications
https://www.pharmalive.com/the-pros-and-cons-of-using-ai-in-developing-scientific-communications/